Platelet-activating factor receptor-mediated PI3KAKT activation contributes to the malignant development of esophageal squamous cell carcinoma

Oncogene(2015),1–14
©2015MacmillanPublishersLimitedAllrightsreserved0950-9232/15doc.guandang.net
ORIGINALARTICLE
Platelet-activatingfactorreceptor-mediatedPI3K/AKTactivationcontributestothemalignantdevelopmentofesophagealsquamouscellcarcinoma
JChen1,6,TLan1,2,6,WZhang1,LDong1,NKang1,SZhang1,MFu1,BLiu3,KLiu4,CZhang5,JHou5andQZhan1
INTRODUCTION
Esophagealsquamouscellcarcinoma(ESCC)isoneofthemostcommonmalignanciesworldwideandoccursatarelativelyhighfrequencyinChina.1Currently,therearelimitedclinicalapproachesfortheearlydiagnosisandtreatmentofESCC,resultinginpooroutcomeofESCCpatientswith10%5-yearsurvivalrateforpatients.ComprehensiveunderstandingoftheetiologyandmechanismsofESCCdevelopmentwillcontributetotheidenti cationofnoveltargetsassociatedwithESCC,whichinturnisimportantforearlydetection,diagnosisandtargetedtreatmentofthismalignancy.
G-protein-coupledreceptors(GPCRs),thelargestfamilyofcell-surfacemolecules,allshareacharacteristiccorecomposedofseven-transmembraneα-helices.2Followingoverexpressionorspeci cligandbinding,GPCRsenhancetheactivityofG-proteinheterotrimer,whichcontainsα,βandγsubunitsandsubsequentlyactivatesthedownstreamsignalingpathways.AberrantGPCRexpressionandthederegulationofligand–receptorinteractionpromotesmalignantcellulartransformationandarecloselyrelatedtotheclinicalprogressioninbothsolidandhematologicalcancers,includingbreastcancer,headandneckcancer,lungcancer,ovariancancerandleukemia.3–7
Recently,aseriesofstudieshaveproposedGPCRderegulationinhumanESCCandestablishedtherelationshipbetweenGPCRsandthemalignantphenotypesofESCC.Forexample,Liuetal.8
12
havereportedthatβ-adrenoceptor,theclassicalGPCR,synergis-ticallyinteractswithEGFRsignalingtopromotethegrowthofESCCcells.8CCchemokinereceptor-7(CCR7)hasbeenfoundtohavearoleinthelymphnodemetastasisofESCCcellsbyinteractingwithitsligandCCL21.9Furthermore,GPCR56,aclassicBsecretin-likeGPCR,hasbeenshowntocorrelatewithtumorigenesisofESCC.10
Theplatelet-activatingfactorreceptor(PAFR),receivingthesignalingfromPAFs,hasbeenidenti edasamemberofGPCRs.11PAFRisinvolvedintheinitiationofsignalingtransmissionthroughtherecruitmentofreceptorkinasesandsmallGTPases,includingGαi,GαoandGαqsubunits.12–16Recently,PAFRhasbeenfoundtobeelevatedinovariancancer.17Moreimportantly,PAFRdown-regulationinhibitstheproliferationandmetastasisofovariancancer,breastcancerandmelanomainvitroandinvivo,suggestingapotentialoncogenicfunctionofPAFR.17–19Never-theless,theresultshavebeeninconsistent.AnotherreporthassuggestedthatPAFRknockoutmiceexhibitsigni cantlyincreasedcarcinogenesisinthepresenceofchemicalcarcinogens.20However,theroleofPAFRinESCCremainstobeelucidated.Inthisstudy,wesurveyedtheexpressionofPAFRinclinicalESCCsamplesandobservedatightassociationofPAFRexpressionwithpoorclinicaloutcomeofESCCpatients.SuchanassociationwasfurthervalidatedinESCCcelllinesbothinvitroandinvivo.Importantly,weidenti edPAFRasanupstreamregulatorof
StateKeyLaboratoryofMolecularOncology,CancerInstituteandHospital,ChineseAcademyofMedicalSciencesandPekingUnionMedicalCollege,Beijing,China;DepartmentofNeurosurgery,BeijingSanboBrainHospital,CapitalMedicalUniversity,Beijing,China;3DepartmentofPharmacology,SchoolofPharmacy,GuangdongPharmaceuticalUniversity,Guangzhou,China;4NationalKeyLaboratoryofMedicalMolecularBiology,InstituteofBasicMedicalSciences,PekingUnionMedicalCollege,TsinghuaUniversityandChineseAcademyofMedicalSciences,Beijing,Chinaand5InstituteofBasicMedicalSciencesofXiyuanHospital,ChinaAcademyofChineseMedicalSciences,Beijing,China.Correspondence:DrQZhan,StateKeyLaboratoryofMolecularOncology,CancerInstituteandHospital,ChineseAcademyofMedicalSciencesandPekingUnionMedicalCollege,Beijing100021China.E-mail:zhanqimin@pumc.edu.cn6
Theseauthorscontributedequallytothiswork.
Received9June2014;revised16October2014;accepted8November2014
mediated by the TRAF (TNF Receptor-Associated ...Raf1 contributes directly to ERK activation but ...(Activating Transcription Factor-2), NFAT4 (...
实验研究发现 血小板活化因子受体拮抗剂(platelet-activating factor receptor ...Activation of p38 MAPK is a key step in tumor necrosis factor-mediated ...
platelet activating factor receptor and the ...EGb 761-mediated NR activation and DME induction....K. Chang. Ginkgolide A contributes to the ...
PAF 发挥生物学作用主要是通过与血 小板活化因子受体(platelet activating factor receptor, PAF-R) 结合而实现的,通过 G 蛋白转导激活磷脂酶 C、 磷脂酶 A2、 ...
-mediated autocrine signaling pathway contributes to...(2004) Activating mutations in the epidermal ... for fibroblast growth factor receptor activation. ...
13 No. 10 2002 - 10 出版 s platelet activating factor receptor antagonist Xia Shihai , Zhao Xiaoyan , Guo Ping , Zhang Weilong , Ren Wanying ,and ...
目的研究体外培养皮质及海马神经元损伤后血小板活化因子受体(platelet activating factor receptor,PAFR)的表达及其与环氧化酶2(cyclooxygenase-2,COX-2)和谷氨酸受体2...
Preventive and remedial application of PAF receptor antagonist (Ginkgolide B)...70 : 196. platelet activation induced by platelet activating factor (PAF) ...
Alkali - induced comeal s tromal melting2 prevention by a novel platelet - activating factor receptor antagonist. Arch Ophthalmol , 2006 , 124( 1) : ...
Raghuwanshi SK.Activation and regulation of platelet—activating factor receptor:Role of Gi and Gq in receptor-mediated chemotactic,cytotoxic,and f23】Liu Y...
热门文档